Reply  by Bergeron, Patrice
With that said, by publishing our experience we are not
advocating endovascular treatment of all spontaneous dissections.
We clearly wrote that this approach is indicated “when medical
therapy is insufficient or inappropriate.” However, in selected
patients with ongoing symptoms despite medical therapy or those
who present with an acute stroke, endovascular therapy should
be considered. Endovascular therapy carries risk, of course, but
Drs. Norris and Menon overemphasize the importance of a slight
iatrogenic intimal tear, which was the only procedural complica-
tion in our series and which healed spontaneously. In regard to
their statement about the risk of reperfusion/hyperperfusion hem-
orrhage after revascularization, we could not agree more, and to
prevent such an event, it is important to preserve as much viable
brain tissue as possible and to control arterial hypertension. Our
patient who had an intracerebral hemorrhage 13 days after stenting
of both internal carotid artery dissections had presented in a coma
from bilateral, severely flow-limiting, internal carotid artery dissec-
tions. In this patient we believed that the risk of an intracerebral
hemorrhage after stenting was acceptable given the almost certain
mortality from acute bilateral internal carotid artery occlusions,
which is not a “benign lesion,” as Drs. Norris and Menon suggest.
In summary, we agree with the sentiment of the comments
offered by Drs. Norris andMenon, but we believe that each patient
with cerebral ischemia should be evaluated as an individual and
that treatment decisions should be made with the unique needs of
each patient taken into account. Sometimes this can mean an endo-
vascular approach even when medicine is the traditional therapy.
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Regarding “Long-term results of carotid stenting are
competitive with surgery”
The article by Bergeron et al1 on the “Long-term results of
carotid stenting are competitive with surgery” concludes that
the results of stenting are competitive with carotid endarterec-
tomy. The study evaluated 221 carotid stents in 193 patients.
After inspection of the data in Table I, the sum of the totals for
Complications of the individual risk factors, lesion factor, and
technical factors plus the total for No complication of the same
individual risk factor, lesion factor, and technical factors are
221 stents. Similarly, in Tables III and IV, the sum of the total
for lesion factors for In-stent restenosis plus the total for Free
from in-stent restenosis is 221 stents; this is also apparent for
the sum of the totals for technical factors. Since the higher than
expected totals are the “global number of patients,” can the
authors define global number ?
Carotid endarterectomy can be achieved with low periopera-
tive complications and is the gold standard for stenting. The 5-,
10-, and 15-year restenosis-free rates and stroke-free rates with the
vein-patch are 91%, 87% and 79%, and 97%, 94% and 93%, respec-
tively.2 The long-term benefit of carotid artery stenting is an
important issue, and an explanation for the increased total number
in the data that was used to obtain their conclusion will help to
weigh the importance of this paper to determine which procedure
would most benefit a patient.
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Reply
We first intended to publish our experience in endovascular
procedures in carotid arteries, including stenting and balloon
angioplasty in stenoses and aneurysms. After we performed the first
Fisher exact test on this larger cohort, we decided to refine our
results and focus on carotid stenting only for stenotic carotid
diseases. Thus, we withdrew sole balloon angioplasty and carotid
artery aneurysms from the cohort, and the period of the study was
retrospectively extended to September 2003. Unfortunately, the
statistician who performed the initial Fisher’s test died soon after,
and we decided to submit the final manuscript without repeating
the Fisher test on the newly defined cohort that was reported in the
manuscript.
We have subsequently performed a Fisher exact test on the
cohort that we described in our Methods section (ie, without
carotid aneurysms and without sole balloon angioplasty). Of the
seven factors that were found to be independently associated with
neurologic complications after all carotid endovascular interven-
tions, only two have remained statistically significant predictors
with similar P values: preoperative renal insufficiency and age70
years. The use of the femoral access rather than the direct cervical
puncture showed a fivefold increase in the neurologic complica-
tions rate that was not statistically significant. As for predictors of
in-stent restenosis, the Fisher exact test on this cohort did not
demonstrate any predicting factor.
On behalf of all my coworkers and coauthors, I thank Dr
Chang for reviewing our results so cautiously and for pointing out
the dataset shifting between the two cohorts we described in our
Methods and Results sections. Although this error only affected the
results of the Fisher exact test, it has been useful to redo the tests
and confirm that preoperative renal insufficiency and age70 years
are indeed independent predictors of neurologic complications
after carotid stenting. This has also resulted in an erratum pub-
lished in this issue of the Journal of Vascular Surgery.
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